You are here

  • Home
  • Archive
  • Volume 19, Issue 6
  • Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment

https://doi.org/10.1136/ebmed-2014-110051

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors IG drafted the work, GB revised the work. They both gave the final approval to the version submitted.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.